Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
Unlike earlier treatments that target only one pathway, retatrutide works across multiple metabolic systems to reduce appetite, stabilize blood sugar, and increase fat burning simultaneously
Not everyone is a candidate, and some patients may do well without prescription therapy
It has also been shown to improve lipid profiles, including reductions in total cholesterol, LDL cholesterol, and triglyceride levels
The benefits of medically supervised injections extend beyond weight reduction
Author contributions RD: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Writing original draft, Writing review & editing